MIFH
PACB icon

Migdal Insurance & Financial Holdings’s Pacific Biosciences PACB Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-35,786
Closed -$1.19M – 648
2021
Q1 		$1.19M Buy
35,786
+22,208
+164% +$777K 0.01% 228
2020
Q4 		$352K Buy
+13,578
New +$231K ﹤0.01% 244

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Migdal Insurance & Financial Holdings's PACB Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Pacific Biosciences (PACB) in Q2 2021, closing a stake of 35,786 shares — an estimated $1.19M sold.

Migdal Insurance & Financial Holdings first reported a position in PACB in Q4 2020 and held it in 2 quarters. The position peaked at $1.19M in Q1 2021. 262 funds tracked by Wall St. Rank hold PACB as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Pacific Biosciences position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 35,786 Pacific Biosciences shares in Q2 2021, an estimated $1.19M.
  • Migdal Insurance & Financial Holdings first reported a position in Pacific Biosciences in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Pacific Biosciences position peaked at $1.19M in Q1 2021.
  • 262 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.